both ETCOc and STB were performed at 30 ± 6 hours of life; STB also was measured at 96 ± 12 hours and subsequently following a flow diagram based on a table of hours of age -specific STB. An infant was defined as hyperbilirubinemic if the hours of age -specific STB was greater than or equal to the 95th percentile as defined by the table at any time during the study.
RESULTS:
A total of 120 ( 8.8% ) of the enrolled infants became hyperbilirubinemic. Mean STB in breast -fed infants was 8.92 ± 4.37 mg / dl at 96 hours versus 7.63 ± 3.58 mg / dl in those fed formula only. The mean ETCOc at 30 ± 6 hours for the total population was 1.48 ± 0.49 ppm, whereas those of nonhyperbilirubinemic and hyperbilirubinemic infants were 1.45 ± 0.47 and 1.81 ± 0.59 ppm, respectively. Seventy -six percent ( 92 of 120 ) of hyperbilirubinemic infants had ETCOc greater than the population mean. An ETCOc greater than the population mean at 30 ± 6 hours yielded a 13.0% positive predictive value ( PPV ) and a 95.8% negative predictive value ( NPV ) for STB !95th percentile. When infants with STB !95th percentile at < 36 hours of age were excluded, the STB at 30 ± 6 hours yielded a 16.7% PPV and a 98.1% NPV for STB > 75th percentile. The combination of these two measurements at 30 ± 6 hours ( either ETCOc more than the population mean or STB > 75th percentile ) had a 6.4% PPV with a 99.0% NPV.
CONCLUSIONS:
This prospective cohort study supports previous observations that measuring STB before discharge may provide some assistance in predicting an infant's risk for developing hyperbilirubinemia. The addition of an ETCOc measurement provides insight into the processes that contribute to the condition but does not materially improve the predictive ability of an hours of age -specific STB in this study population. The combination of STB and ETCOc as early as 30 ± 6 hours may identify infants with increased bilirubin production ( eg, hemolysis ) or decreased elimination ( conjugation defects ) as well as infants who require early follow -up after discharge for jaundice or other clinical problems such as late anemia. Depending on the incidence of hyperbilirubinemia within an institution, the criteria for decision making should vary according to its unique population. Journal of Perinatology 2001; 21:S63 -S72.
Original Article
breast-feeding, and the detection of jaundice. 1 In 1994, the American Academy of Pediatrics (AAP) published a practice guideline to provide pediatric practitioners with criteria for safe and early management of hyperbilirubinemia in healthy term neonates. 2 However, compliance with the guideline often is lacking. For example, many pediatricians do not exclude infants with hemolysis or those <37 weeks' gestation, as suggested in the guideline. This has led to the inappropriate early discharge of infants with unrecognized hemolytic disease, as well as near-term infants who are having difficulty with feeding. A recent report 3 reconfirmed that hyperbilirubinemia and problems related to feeding are the main reasons for hospital readmission during the first week of life. 4 -7 The AAP practice guideline relies on the ability of the physician to recognize significant jaundice as an indication for the determination of serum total bilirubin (STB) levels. Unfortunately, there is considerable variability in the accuracy of assessing the degree of jaundice among observers. 8, 9 Furthermore, with very early discharge, modest but unacceptable elevation of the STB might not be recognized clinically, thus placing the infant at risk for severe hyperbilirubinemia (STB !95th percentile). 10 The AAP guideline also requires that hemolysis be ruled out in infants who exhibit significant jaundice. The measurement of carbon monoxide (CO) in end-tidal breath corrected for ambient CO (ETCOc), an index of total bilirubin production, can alert the physician to possible hemolysis as well as other conditions associated with increased bilirubin production irrespective of timing or presence of jaundice. 11 -14 Moreover, the combination of hours of age-specific STB and ETCOc measurements may provide valuable insight into the dynamics of bilirubin production and elimination in individual infants. This practice also may improve the early recognition of infants who are at risk for severe hyperbilirubinemia after discharge and who may require close follow-up and/or additional diagnostic evaluation.
The objective of this study was to determine whether a measurement of ETCOc obtained 30±6 hours after birth alone or in combination with an STB measurement obtained at the same time could predict the development of severe hyperbilirubinemia during the first 7 days (168 hours) of life with a high sensitivity and an acceptable specificity for practical clinical use.
METHODS

Participant Criteria
Infants were eligible for the study if their gestational age was !35 weeks as determined by best obstetric estimate and if enrollment could be accomplished within the first 36 hours of life during the period of February 20, 1998 through February 22, 1999 . Exclusion criteria were neonates having any illness that would require admission to the neonatal intensive care unit (NICU) before 24 hours (a workup to rule out sepsis in a neonate who appeared to be well or maternal treatment with antibiotics were not exclusion criteria) or severe congenital anomalies. Also excluded were infants who were in incubators; who had pulmonary disease requiring oxygen or ventilatory assistance via hood, tent, nasal cannula, continuous positive airway pressure, or ventilator; who had significant nasal obstruction in either naris; who had a birth weight of 850 g or less; or who had respiratory rates 10 or !100 breaths per minute (operating range for the CO-Stat End-Tidal Breath Analyzer [Natus Medical, San Carlos, CA]).
Study Design
This cohort study included all infants who met the eligibility criteria and for whom informed consent was obtained and had mandatory measurements of ETCOc and STB performed at 30±6 hours of age and STB at 96±12 hours. Additional STB measurements were performed according to a flow diagram ( Figure 1 ) and an hourly bilirubin 13, 14 The device was calibrated locally every 30 days. The accuracy of the analyzer is ±0.3 ppm (or l/l) or 10% of the reading (whichever is greater) for respiratory rates between 10 and 60 breaths/min and ±0.3 ppm or 15% of the reading (whichever is greater) for breathing rates >60. In a previous bedside evaluation study of the instruments, 13 the reproducibility and coefficient of variation of ETCOc measurements when sampling neonates and adults were determined to be better than other methods tested, such as hand sampling and semiautomatic electrochemical detection. In addition to ETCOc, other parameters measured by the device include breath CO concentration (uncorrected for ambient CO), ambient CO concentration (reflecting inhaled air), end-tidal carbon dioxide (ETCO 2 ), and respiratory rate. The device uses sidestream sampling to draw nasal air continuously through the sampler at 60 ml/min. The sampler is made of a clear polymer with an inner and outer diameter of 0.8 and 1.5 mm, respectively. Adhesive wings (8Â5 mm) allow a maximum insertion depth at 6.0 mm before coming into contact with the lower edge of the nostril. Because participants are not required to control their breathing patterns, this device can be used with infants and others who are unable to accomplish breath control.
Blood was collected and the serum was analyzed for STB in each enrolled infant (Figure 1 15 Infants were defined as hyperbilirubinemic if their hours of age-specific STB at any time during the study was !95th percentile, as defined by Table 1 . In addition, during the first 24 hours, the attending physician had the option of measuring the STB for an infant who exhibited visible jaundice. For infants whose STB was !95th percentile, an ETCOc measurement was performed and the infant was excluded from further study. Infants who were not excluded before 24 hours had the first scheduled STB and ETCOc measurements performed at 30±6 hours in coordination with state-mandated newborn screening for inborn errors of metabolism and additional required tests. Infants with STB !95th percentile exited the study at this time. All other infants remained in the study. From 24 to 84 hours. measurements of STB were performed at the discretion of the physician. If the physician elected to perform an STB between 24 and 84 hours, then the inTable 1fant exited the study if the level was !95th percentile. If the STB was not !95th percentile or if no STB was obtained between 24 and 84 hours, then the infant had a mandatory STB performed at 96±12 hours. If the STB was !95th percentile or <40th percentile, then the infant exited the study. Any STB between the 40th and the 94th percentiles required a repeat STB in 24 to 48 hours based on the result. If the 96±12 hour measurement was !75th percentile and <95th percentile, then the STB was repeated within 24 hours. If the 96±12 hour measurement was >40th percentile and 75th percentile, then the STB was repeated within 48 hours. An infant who had an STB between the 40th and 94th percentiles continued to have STB measured every 24 to 48 hours until the STB was !95th percentile or <40th percentile, the most recent STB was less than or equal to the STB result 24 to 48 hours earlier, or the infant attained 168 hours of life. At 168 hours, all infants exited the study with ongoing care provided at the discretion of the physician.
Statistical Methods
Of the 1895 participants who were enrolled in the study, 1370 completed the study. Of the excluded infants, 88 were enrolled in the study but did not participate in the testing, 272 were lost to followup, 131 had technical problems with preproduction samplers, 32 could not be tested with the CO-Stat device for other reasons (e.g., hydrogen interference, irregular breath patterns), and 175 did not adhere to the study protocol. In addition, another 131 infants were tested at a 10th site but were excluded from analysis because measurements of STB were taken with a transcutaneous bilirubinometer rather than performed with the standard blood test. Some infants were excluded for multiple reasons.
The study was conducted in two phases. In phase I, 577 infants were tested with a preproduction CO-Stat nasal sampler; in phase II, 793 infants were tested with the production sampler. The ETCOc results from phase I showed a higher mean±standard deviation (SD) than those values from phase II (1.70±0.54 vs. 1.48±0.49 ppm, respectively). This was attributable to a slight outgassing of CO from a material used in the preproduction sampler. The ETCOc data from the two phases of the study were combined and normalized by converting the measurements to Z scores (i.e., standardized deviation of the measurement from the mean, in SD units). All analyses were conducted in Z units, and the ETCOc values reported throughout this article have been converted back to parts per million (ppm) with the distribution having the mean and SD of phase II.
Receiver operator characteristic (ROC) analyses 16 -18 for the prediction of hyperbilirubinemia were performed for three different parameters of predicting hyperbilirubinemia: ETCOc at 30±6 hours, STB percentile (as defined by the table) at 30±6 hours, and a combination of STB and ETCOc test at 30±6 hours. A positive result for the combined test was defined as either an STB between the 75th and 95th percentile or an ETCOc greater than the population mean or both at 30±6 hours. Infants who presented with STB !95th percentile at 30±6 hours were excluded from the STB and combined ROC analyses because they had been found to be hyperbilirubinemic at the predicting measurement. These infants were not excluded from the ETCOc ROC analysis, because the predicting and outcome measurements were different although they occurred in the same time window.
Two stepwise logistics regression analysis models for the prediction of hyperbilirubinemic (as defined above) were performed on the data: 1 for noninvasive (i.e., ETCOc) measurements and 1 for invasive measurements (i.e., STB). The following variables were used in the noninvasive model: ETCOc at 30±6 hours, presence of bruising, feeding type (breast milk, formula, or both), birth weight, race (Asian, white or Hispanic, black, other), maternal diabetes, type of labor (vaginal or cesarean section), gender, infection, cephalhematoma, pregnancy-induced hypertension/pre-eclampsia, gravidity, parity, maternal blood type, and maternal Rh status.
At each step in building the first model, the variable that reduced the total squared error was added first. Two stopping rules were used: (1) the addition of the next variable reduced the overall squared error by <1%, and (2) the probability of hyperbilirubinemia was not statistically different for the candidate variable to be added to the model.
RESULTS
The distribution of STB for the total population at 30±6 and 96±12 hours show that approximately 9% (120 of 1370) of infants had an STB !95th percentile. Four of 620 (0.65%, with a 95% confidence interval of 0.02% to 1.30%) infants had an STB <40th percentile at 30±6 hours but subsequently had an STB >95th percentile. Infants who were breast-fed had higher mean STB levels at 96 hours (8.92±4.37 mg/dl) compared with those who were fed formula exclusively (7.63±3.58 mg/dl; p<0.0001).
The distribution of ETCOc at 30±6 hours is shown in Figure 2 . The mean ETCOc for the total population (n=1370) was 1.48±0.49 ppm (range: 0.2 to 3.5; median: 1.5) at 30±6 hours of life ( Table 2 ). The mean ETCOc for the nonhyperbilirubinemic infants (n=1250) was 1.45±0.47 ppm (range: 0.1 to 3.1; median: 1.4) compared with 1.81±0.59 ppm (range: 0.4 to 3.6; median: 1.9) for the hyperbilirubinemic infants (n=120; p<0.0001). Ninety-two (76%) of 120, hyperbilirubinemic participants had an ETCOc greater than the total population mean. Center variabilities of the mean ETCOc at 30±6 hours of each site's total population and of infants with STB !95th percentile are shown in Table 3 . Logistic regressions show that the following variables were found to be significant for the first stopping rule (in order of addition): ETCOc, feeding type, birth weight, race, parity, maternal diabetes, maternal blood type, and bruising. The second, more conservative, stopping rule found (in order of addition) ETCOc, feeding type, and birth weight to be the most significant variables.
The second logistic regression analysis model included the above variables as inputs as well as the STB percentiles at the 30±6 hour measurement as defined by Table 1 . For this analysis, the following variables were found to be significant (in order of addition): STB percentile, bruising, maternal blood type, race, maternal diabetes, feeding type, gravidity, and ETCOc. The more conservative stopping rule found that only STB percentile and bruising were significant. ROC curves are shown in Figure 3 . For the three parameters of predicting hyperbilirubinemia at a specificity of 80% (1Àspecificity=20%), the sensitivity at 30±6 hours ranges from approximately 50% (ETCOc alone) to approximately 65% (with 30±6 hour STB). For 50% specificity, the sensitivities increase to 75% and 90%. Positive and negative predictive values (PPV and NPV, respectively) were calculated. ETCOc greater than mean at 30±6 hours yielded a 13.0% PPV with a 95.8% NPV (Table 4) . STB >75th percentile at 30±6 hours resulted in a 16.7% PPV with a 98.1% NPV when infants with STB >95th percentile at <36 hours of age were excluded. The combination of the two measurements if either ETCOc was more than the mean or STB >75th percentile yielded a 6.4% PPV with a 99.0% NPV as a result of the low prevalence of hyperbilirubinemia in the study population. With these levels of sensitivity and specificity, the PPV and NPV of early (30±6 hours) measurements of ETCOc or ETCOc in combination with STB for reliable prediction of hyperbilirubinemia are not achievable.
DISCUSSION
Neonatal jaundice is a syndrome with many causes but, ultimately, is the result of an imbalance between bilirubin production and elimination. On the basis of a nomogram for hours of age-specific STB levels, 10 120 (8.8%) of 1370 infants had an STB !95th percentile between 24 and 36 hours and 168 hours of life. Total bilirubin formation, as indexed by ETCOc, was 24.7% higher in the hyperbilirubinemic infants with the majority (76%) of these infants having an ETCOc greater than the mean of the whole population. However, it is important to note that some infants with very low bilirubin production still become hyperbilirubinemic. This strongly suggests that the elimination of bilirubin is sufficiently impaired to cause significant jaundice in approximately one quarter of the infants who develop hyperbilirubinemia. Conversely, many infants with high bilirubin production rates do not develop significant jaundice because they can deal with this increased load. Thus, given the low prevalence of severe hyperbilirubinemia, it was unlikely that either an hours of age-specific STB or ETCOc, alone or in combination, would have a high PPV, which is what was observed in this study. Nonetheless, the combination of STB and ETCOc measurements provides insight into the underlying processes that give rise to hyperbilirubinemia but does not materially improve the predictive ability of an hours of age-specific STB in this study population. For instance, if both STB and ETCOc measurements fall below a set threshold, the least worrisome circumstance could be assumed. Thus, the absence of both an elevated hours of age-specific STB and elevated ETCOc, which has a high NPV, would support the clinical decision to limit laboratory testing and to shorten the hospital stay for such low-risk infants.
On the basis of a review of the ROC curves, a clinician might be tempted to rely on STB alone for the prediction of hyperbilirubinemia. Practically, this decision would not be unreasonable because increased bilirubin production, as indexed by ETCOc, is a major component of most hyperbilirubinemia as indicated by the proportion of infants (76%) with increased bilirubin production in the hyperbilirubinemic group. However, an ETCOc measurement in combination with the STB identifies precisely those infants who are most likely to have hemolysis versus those with conjugation incapacities, such as Gilbert's disease 19 -21 or the G71R missense mutation in the bilirubin glucuronosyltransferase gene. 22 The added benefit of diagnosing hemolysis by measurement of the ETCOc ensures compliance with the AAP guideline that requires identification of infants with increased hemolysis. 2 In addition, the possibility of diagnosing conjugation defects becomes more likely among infants with a high STB and a normal or low ETCOc. Moreover, improved diagnostic differentiation of jaundiced infants might direct specific therapeutic interventions as new treatment options become available, for example, metalloporphyrin therapy for high producers of the pigment 23 -26 or gene therapy for conjugation defects. 27 In the meantime, high-risk infants could be targeted for close follow-up to avoid unexpected significant hyperbilirubinemia and readmission to the hospital.
In fact, logistic regression models can be used to predict later significant elevation in STB. Without using STB at 30±6 hours as a predictor, the variables that are most significant are (in order of addition) ETCOc, feeding type, birth weight, race, parity, maternal diabetes, maternal blood type, and bruising. A simplified model, generated by using a rule to stop adding variables when the category of the variable was not significantly different with regard to the probability of hyperbilirubinemia, includes three variables: ETCOc, feeding type, and birth weight. Thus, increased bilirubin production, exclusive breast-feeding, and birth weight (a likely surrogate for gestational age in this study, which included infants with gestational ages !35 weeks) represent useful predictors for whether a particular infants develops hyperbilirubinemia. The STB percentile at 30±6 hours, together with the presence of bruising (a surrogate for increased bilirubin production), provides a simplified prediction model, somewhat superior to ETCOc and the other variables available.
The common practice of using Coombs' testing as a surrogate for the identification of hemolysis is not a reliable strategy. In this study, only 18.5% (10 of 54) of infants with a positive direct Coombs' test had an STB !95th percentile and mean ETCOc values of 1.89±0.63 ppm (p<0.00932 when compared with the population mean), suggesting that most infants with a positive direct Coombs' test either can handle the bilirubin load well or do not have hemolysis. Conversely, 54 (10.4%) of 519 infants who had STB !95th percentile and a mean ETCOc value of 1.89±0.55 ppm had a negative direct Coombs' test, consistent with the possibility that some infants with a negative direct Coombs' test may have a hemolysis. Although not all infants (only 573 of 1370, or 41.8%) had a Coombs' test performed during the course of this study, these observations suggest that an ETCOc measurement might represent a more direct way to identify noninvasively infants who do not need Coombs' testing or other laboratory tests before discharge and routine follow-up.
In addition, the guidelines for management of hyperbilirubinemia may need to vary between centers, as the percentage of infants with STB !95th percentile as based on a US population varied from 5% to 39% among centers ( Table 3 ). The propensity for jaundice in a particular population was variably related to increased ETCOc, suggesting that defects in conjugation or persistent enterohepatic circulation of bilirubin play important causative roles among infants in certain settings. The marked increased percentage of infants with STB !95th percentile in Kobe, Japan, is consistent with the high proportion of infants with defective glucuronosyltransferase in this population. 22 It also is interesting to note that the Chinese population in this study had a lower incidence of hyperbilirubinemia than previously reported, 28 -30 which suggests that there may have been changes in environmental factors. There also was a high incidence observed in the Jewish population and may be due to the small sample size of this group. Furthermore, it is interesting to note that in our total population, 4 (0.65%) of 620 infants had an STB <40th percentile at 30±6 hours but nevertheless subsequently developed an STB !95th percentile. In addition, the differences in the percentage of infants with STB !95th percentile observed at each center also may be confounded by the known interlaboratory variability in STB measurements. 13 This fact alone warrants the use of other measurement parameters, in concert or alone, to provide additional information for the identification and follow-up of infants who are at risk for hyperbilirubinemia.
Breast-feeding was associated with a slight increase in the STB, and, as indicated by the ETCOc, there was increased bilirubin production associated with breast-feeding. Although increased production was not observed previously in smaller studies 11, 31 relative caloric deprivation associated with the initiation of exclusive breastfeeding perhaps could explain this phenomenon. 32 More important, the possibility that increased bilirubin production compounds the effect of an increased enterohepatic circulation in exclusively breastfed infants support further the clinical observation that breast-fedonly infants have a propensity for higher STB levels after birth and suggests that the definition of physiologic jaundice should be reconsidered in this context. Furthermore, in addition to identifying infants with hemolysis or other causes of increased bilirubin production, the need to observe closely and evaluate the adequacy of breast-feeding before discharge might reduce both morbidity and the frequency of readmission to the hospital. 33 We also confirmed that hemolysis and bruising, as expected, increased bilirubin production and the propensity for jaundice.
CONCLUSION
This prospective cohort study supports previous observations that the practice of measuring STB before discharge may provide some assistance in predicting infants who are at risk for the subsequent development of hyperbilirubinemia. 10, 34, 35 However, this measurement together with an ETCOc provides insight into the processes that contribute to the condition. The combination of STB and ETCOc measurements as early as 30±6 hours of life will increase the chance of identifying an infant with hemolysis or other causes of increased bilirubin production as well as infants with conjugation defects. Such combination screening could identify infants who might need early intervention with phototherapy or additional diagnostic workup and/or follow-up for jaundice after discharge. It is important to recognize that infants with increased bilirubin production, who may handle the bilirubin load well, also may have other clinical problems that require diagnosis and follow-up, such as late anemia in the presence of hemolysis. Finally, differences in the incidence of hyperbilirubinemia and its causes may vary from one center to another. Although the screening procedures might be similar across institutions, the criteria used for decision making may need to vary depending on the prevalence and unique characteristics of the particular population and practice patterns.
